DE60106647T2 - Klare propofolzusammensetzungen - Google Patents

Klare propofolzusammensetzungen Download PDF

Info

Publication number
DE60106647T2
DE60106647T2 DE60106647T DE60106647T DE60106647T2 DE 60106647 T2 DE60106647 T2 DE 60106647T2 DE 60106647 T DE60106647 T DE 60106647T DE 60106647 T DE60106647 T DE 60106647T DE 60106647 T2 DE60106647 T2 DE 60106647T2
Authority
DE
Germany
Prior art keywords
composition
clear
tpgs
parenteral administration
propofol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60106647T
Other languages
German (de)
English (en)
Other versions
DE60106647D1 (de
Inventor
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Shilpa Sudhakar School KOCHAREKAR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bharat Serums and Vaccines Ltd
Original Assignee
Bharat Serums and Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums and Vaccines Ltd filed Critical Bharat Serums and Vaccines Ltd
Publication of DE60106647D1 publication Critical patent/DE60106647D1/de
Application granted granted Critical
Publication of DE60106647T2 publication Critical patent/DE60106647T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60106647T 2000-12-07 2001-12-05 Klare propofolzusammensetzungen Expired - Fee Related DE60106647T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (enExample) 2000-12-07 2000-12-07
INDE110600 2000-12-07
PCT/IN2001/000213 WO2002045709A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions

Publications (2)

Publication Number Publication Date
DE60106647D1 DE60106647D1 (de) 2004-11-25
DE60106647T2 true DE60106647T2 (de) 2005-11-10

Family

ID=11097320

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60106647T Expired - Fee Related DE60106647T2 (de) 2000-12-07 2001-12-05 Klare propofolzusammensetzungen

Country Status (13)

Country Link
US (1) US20040235964A1 (enExample)
EP (1) EP1351669B1 (enExample)
CN (1) CN1283235C (enExample)
AT (1) ATE279917T1 (enExample)
AU (1) AU2002217418A1 (enExample)
CA (1) CA2432549A1 (enExample)
DE (1) DE60106647T2 (enExample)
ES (1) ES2231583T3 (enExample)
IN (1) IN188917B (enExample)
MX (1) MX228228B (enExample)
RU (1) RU2257892C2 (enExample)
WO (1) WO2002045709A1 (enExample)
ZA (1) ZA200304981B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
NZ538255A (en) 2002-07-29 2006-11-30 Transform Pharmaceuticals Inc Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) * 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
CN100479812C (zh) 2004-02-13 2009-04-22 生物药效率有限公司 麻醉用高浓度异丙酚微乳制剂
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
MX2010010050A (es) 2008-03-20 2011-03-15 Virun Inc Star Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
AT514764A1 (de) * 2013-09-02 2015-03-15 Sanochemia Ag Beta-Carotin Zubereitung
US11266621B1 (en) * 2014-10-02 2022-03-08 Exela Sterile Medicines Llc Methocarbamol composition and related methods
CN108601732A (zh) * 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
US20190330260A1 (en) 2016-12-21 2019-10-31 Avecho Biotechnology Limited Process
CN114601800B (zh) * 2021-09-28 2023-07-28 天津瑞普生物技术股份有限公司 一种甲磷丙泊酚钠无菌粉针剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
CA2319810C (en) * 1998-02-10 2008-12-23 Gensia Sicor Inc. Propofol composition containing sulfite
PT1143962E (pt) * 1999-01-28 2005-03-31 Kurani Shashikant Prabhudas Solucao parenterica de propofol (2,6-di-isopropilfenol) e 2,5-di-o-metil-1,4;3,6-di-anidro-d-glucitol, como dissolvente
ES2261210T3 (es) * 1999-06-21 2006-11-16 Kuhnil Pharmaceutical Co., Ltd. Comoposicion anestesica para inyeccion intravenosa que comprende propofol.
IN187686B (enExample) * 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
US6919370B2 (en) * 2000-11-28 2005-07-19 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
WO2002045709A1 (en) 2002-06-13
CA2432549A1 (en) 2002-06-13
CN1489457A (zh) 2004-04-14
ES2231583T3 (es) 2005-05-16
HK1064954A1 (en) 2005-02-08
US20040235964A1 (en) 2004-11-25
MX228228B (es) 2005-06-01
MXPA03006054A (es) 2003-09-10
DE60106647D1 (de) 2004-11-25
EP1351669A1 (en) 2003-10-15
IN188917B (enExample) 2002-11-23
ZA200304981B (en) 2004-04-23
EP1351669B1 (en) 2004-10-20
RU2257892C2 (ru) 2005-08-10
CN1283235C (zh) 2006-11-08
ATE279917T1 (de) 2004-11-15
AU2002217418A1 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
DE69328192T2 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
DE60106647T2 (de) Klare propofolzusammensetzungen
DE69528714T2 (de) Propofol und disodium edta enthaltende öl-in-wasser emulsionen
DE60001223T2 (de) Tris enthaltende propofol-formulierung
DE69522227T2 (de) Öl-im-wasser-emulsionen enthaltend taxin (taxol) und verfahren
DE69627651T2 (de) Formulierungen und zusammensetzungen von in wasser schwer löslichen camptothecinderivaten
DE69936911T2 (de) Propofolhaltiges arzneimittel enthaltend sulfite
DE69920201T2 (de) Zusammensetzungen enthaltend glykolderivate, alkohole und vitamin d
DE60119082T2 (de) Anästhetikum enthaltende formulierungen
DE60011149T2 (de) Klare wässrige anästhesierende zusammensetzung
DE60215129T3 (de) Esmolol-enthaltende zubereitungen
WO2000040236A1 (de) Taxane enthaltende stabile und sterile emulsion und verfahren zu ihrer herstellung
DE112004001563T5 (de) Säure-haltige Oxaliplatin-Formulierungen
DD244292A5 (de) Trockensubstanzen und stabile suspensionen
DE3782480T2 (de) Gefriergetrocknete arzneimittel mit phenylchinolincarbonsaeuren.
DE69922252T2 (de) Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel
DE3509741A1 (de) Orale dosierungsform von etoposid
DE2451568A1 (de) Verfahren zur herstellung von emulgierbaren pulverfoermigen produkten
DD153760A5 (de) Loesungsmittelgemische und verfahren zur herstellung von parenteral verabreichbaren injektionsloesungen
DE202012013584U1 (de) Pharmazeutische Formulierung enthaltend Curcumin
EP0108248B2 (de) Lösungsvermittlerfreie, wässrige Nitroglycerinlösung
DE3611467A1 (de) Hochresorbierbare zubereitungsform des hymecromons und verfahren zur herstellung derselben
EP1624896B1 (de) Verfahren zur herstellung einer stabilen injizierbaren formulierung von paclitaxel
DE69534696T2 (de) Parenterale Fettemulsionen, die EDTA als Konservierungsmittel enthalten
DE3343818C2 (enExample)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee